The International Atomic Energy Agency (IAEA) invites the global radiopharmaceutical community to the International Symposium on Trends in Radiopharmaceuticals (ISTR 2027), taking place from 21 to 25 June 2027 at the IAEA Headquarters in Vienna, Austria.
The symposium will bring together scientists, clinicians, regulators, industry representatives, educators, and early-career professionals from around the world to discuss the latest developments and challenges shaping the future of radiopharmaceuticals.
ISTR 2027 will provide a global platform for exchanging knowledge and experiences across the full radiopharmaceutical value chain, including medical radioisotope production, radiopharmaceutical development, quality assurance, regulation, preclinical evaluation, education, and clinical applications. The symposium will also address challenges related to supply, availability, capacity building, and equitable access to radiopharmaceuticals.
Call for Abstracts
The IAEA is currently inviting researchers to submit original work for oral and poster presentations covering a broad range of topics in radiopharmaceutical sciences and applications.
Early-career professionals and students are particularly encouraged to participate, with a Young Investigator Award recognizing outstanding contributions.
The deadline for abstract submission is 30 November 2026.
Event Information
Event: International Symposium on Trends in Radiopharmaceuticals (ISTR 2027)
Date: 21–25 June 2027
Venue: IAEA Headquarters, Vienna, Austria
Organizer: International Atomic Energy Agency (IAEA)
Abstract Submission Deadline: 30 November 2026
Further Information
For more information about the symposium and abstract submission, please visit:
Official Website: https://www.iaea.org/events/istr2027
Abstract Submission: https://conferences.iaea.org/event/473/abstracts/
Themes and Topics: https://conferences.iaea.org/event/473/page/1159-themes-topics-and-structure